Hydroxycinnamic acids, abundant in Picholine extra virgin olive oils, show neuroprotective effect against Alzheimer's B-amyloid peptide plaque deposits in the brain.
The Mediterranean diet, particularly the consumption of extra virgin olive oil, has been linked to various health benefits, including reducing oxidative stress which is associated with conditions like Alzheimer’s. Studies have shown that the neuroprotective effects of extra virgin olive oil against AB toxicity in cells may be attributed to the presence of hydroxycinnamic acids, suggesting a potential therapeutic strategy for reducing oxidative stress in neurodegenerative disorders.
The Mediterranean diet is well known for its variety of positive health benefits, many of those benefits attributed to the ample consumption of extra virgin olive oil.
Several studies have recognized the roleextra virgin olive oil plays in reducing oxidative stress, which is a key factor in the pathogenesis of Alzheimer’s and other neurodegenerative conditions.
See Also:Olive Oil Health Benefits
Oxidative stress can cause changes to DNA, lipids and cellular proteins, and neurons are particularly vulnerable to the attacks of free radicals that result as a consequence of oxidative stress.
Although Western countries have a high life expectancy, neurological conditions such as Alzheimer’s are on the rise, which greatly reduce quality of life and place substantial burden on public health services.
Alzheimer’s is characterized by B‑amyloid (AB) peptide plaque deposits in the brain, which is both initiated and driven by oxidative stress.
Nutrition plays an important role in reducing oxidative stress and the development of such conditions as key nutrients provide bioavailable antioxidants and powerful compounds that can mitigate the effects of free radicals.
Extra virgin olive oil is one nutritional agent that has been noted to fight a variety of conditions that are amplified by oxidative stress, including atherosclerosis, cardiovascular disease, and cancers. Most notably, these effects are due to biologically active phenolic compounds that are present in EVOO, including tyrosol, hydroxytyrosol, oleocanthal, oleuropein, oleic acid to name a few.
Other phenolic compounds, hydroxycinnamic acids such as p‑coumaric, ferulic, caffeic and vanillic acids, have been investigated in more than 97 studies and have also been shown to be efficiently absorbed.
Compared to other oil varieties, hydroxycinnamic acids are particularly high in extra virgin olive oils made from the Picholine olive variety. Therefore, a recent study published in Cytotechnology sought to determine the neuroprotective effect of EVOO, with a particular interest in determining if the benefits could be attributed to the hydroxycinnamic acids.
The researchers used a commercial variety of Picholineextra virgin olive oil from Southern France to determine hydroxycinnamic acid concentrations, performing the tests on human neurotropic cells incubated over a total of 90 hours under standard measurement procedures for testing the neuroprotective effect of such agents. The cells were treated with various dilutions ofextra virgin olive oil ranging from low concentrations of 1/10000 to higher concentrations of 1/100.
As expected, higher concentrations did show greater benefits. However, even lower concentrations of 1/10000 to 1/1000 showed thatextra virgin olive oil does have a neuroprotective effect against AB toxicity in certain cells. And more than this, the researchers established that some of this effect is attributed to the hydroxycinnamic acid content.
They suggest further research exploration into foods containing hydroxycinnamic acids could be a promising therapeutic strategy for oxidative stress reduction in neurodegenerative disorders.
More articles on: atherosclerosis, cardiovascular disease, health
Dec. 31, 2025
The 10 Most-Read Olive Oil Times Articles of the Year
From climate pressures and scientific breakthroughs to shifting consumer habits and historic milestones, these were the Olive Oil Times stories that readers returned to the most in 2025.
Dec. 1, 2025
Researchers Warn Ultra-Processed Foods Are Driving a Global Public-Health Crisis
The Lancet warns that ultra-processed foods are driving rising rates of chronic disease, displacing traditional diets and worsening environmental degradation worldwide.
Dec. 5, 2025
In Puglia’s Ancient Groves, a Young Producer Charts a High-Tech Future for Ulivè
Azienda Agricola Emmanuel Sanarica is redefining olive farming in Puglia, combining research, technology and biodiversity to produce award-winning oils such as Ulivè.
Jan. 22, 2026
Study Finds Extra Virgin Olive Oil Improves Vascular Function in Hyperlipidemia Patients
A randomized controlled trial in Greece found that extra virgin olive oil consumption improved vascular function and key cardiovascular markers in patients with hyperlipidemia.
Aug. 25, 2025
Compound Found in Olive Oil Boosts mRNA Vaccine Effectiveness and Safety
Incorporating a phenol group found in olive oil into the mRNA vaccine delivery mechanism mitigated the most common side effects of the vaccine while improving efficiency.
Mar. 26, 2026
At Domaine de Gerbaud, Native Provençal Cultivars Shape an Award-Winning Blend
For Domaine de Gerbaud, blending Aglandau, Salonenque, Grossane and Bouteillan is both technical and expressive, shaped by terroir, organic farming and the realities of climate pressure.
Feb. 23, 2026
Svalbard Seed Vault to Receive First Olive Seeds in Bid to Protect Genetic Diversity
Olive seeds will be deposited for the first time in the Svalbard Global Seed Vault later this month, in a project backed by the International Olive Council and the FAO to safeguard genetic diversity amid mounting climate and disease pressures.
Dec. 15, 2025
Researchers Detect Microplastics in Italian Olive Oils Using New Imaging Technique
A new study published in Food Chemistry found microplastics in Italian extra virgin olive oils, highlighting differences linked to supply chain length and production practices.